Breast cancer �BC� is the most prevalent oncologic pathology in women. It is �elieved that an effectiveness of therapy of this disease could �e improved �y the development of new means for �iologic correction of iron homeostasis as an important factor of sta�le functioning of all �ody systems. New knowledge a�out the role of iron in the development and progression of tumors has �een gained due to the studies of the intracellular content and tissue distri�ution of iron-containing proteins and their receptors.
It is known that at cellular and molecular levels the regulation of iron meta�olism is exerted through the �alanced action of iron-containing proteins� including transporter proteins. Transport of iron in a protein-�ound form minimi�es its capa�ility for participation in the reacminimi�es its capa�ility for participation in the reacminimi�es its capa�ility for participation in the reacits capa�ility for participation in the reacits capa�ility for participation in the reaccapa�ility for participation in the reaccapa�ility for participation in the reacfor participation in the reacfor participation in the reacparticipation in the reacparticipation in the reacin the reacin the reacthe reacthe reacreacreactions of free-radical oxidation� and therefore decreases possi�le oxidative damage of cells and tissues of an oroxidative damage of cells and tissues of an oroxidative damage of cells and tissues of an ordamage of cells and tissues of an ordamage of cells and tissues of an orof cells and tissues of an orof cells and tissues of an orcells and tissues of an orcells and tissues of an orand tissues of an orand tissues of an ortissues of an ortissues of an orof an orof an oran oran oror-organism [�] .
While the meta�olic patterns of such iron-containing proteins as ferritin� transferrin� ferroportin in BC patients are studied in detail . �� is an iron-�inding glycoprotein of transis an iron-�inding glycoprotein of transan iron-�inding glycoprotein of transan iron-�inding glycoprotein of transiron-�inding glycoprotein of transiron-�inding glycoprotein of trans--�inding glycoprotein of trans�inding glycoprotein of transglycoprotein of transglycoprotein of transof transof transferrin family of iron transporter proteins� with a molecular weight of 7�.� kD composed of a single polypeptide chain. �� contains 7�� aminoacids and forms two ho-. �� contains 7�� aminoacids and forms two ho-�� contains 7�� aminoacids and forms two hocontains 7�� aminoacids and forms two hocontains 7�� aminoacids and forms two ho-7�� aminoacids and forms two hoaminoacids and forms two hoforms two hoforms two hotwo hotwo hoho-homological domains� N-and C-parts of which contain an iron-�inding center and have a special function [�] . Different �� isoforms have �een identified. ��-� is ca-�� isoforms have �een identified. ��-� is caisoforms have �een identified. ��-� is ca-��-� is cais caca-capa�le to �ind iron ions �ut has no ri�onuclease activity while isoforms ��-β and -γ exert ri�onuclease activity �ut are incapa�le to �ind metal ions [4] . Apart from this� the protein could exist in iron-saturated form �hololactoferrin� or iron-unsaturated form �apolactoferrin�. One molecule of the protein could �e �ound with two ions of iron� copthe protein could �e �ound with two ions of iron� copthe protein could �e �ound with two ions of iron� copprotein could �e �ound with two ions of iron� copprotein could �e �ound with two ions of iron� copcould �e �ound with two ions of iron� copcould �e �ound with two ions of iron� cop�e �ound with two ions of iron� cop�e �ound with two ions of iron� cop�ound with two ions of iron� cop�ound with two ions of iron� copwith two ions of iron� copwith two ions of iron� coptwo ions of iron� coptwo ions of iron� copions of iron� copions of iron� copof iron� copof iron� copiron� copiron� cop-� cop-copper� �inc or other metals.
Also it has �een shown that some functional features of �� depend on its oligomeric state. As a monomer� �� is capa�le to �ind with DNA and regulate granulopoiesis� while tetrameric form of �� lacks such fea-�� lacks such fealacks such features [5] . It has �een esta�lished that the process of conformational rearrangement of �� with formation of mono-� di-� tri-� or tetrameric forms requires adenosine triphosphate [�] .
In adult human �ody� �� is stored in neutrophils� specific �secondary� granules of which contain large amounts of ��. �� content may vary depending on gen-��. �� content may vary depending on gencontent may vary depending on gender and age� however� the results of different studies are contradictory. After degranulation of neutrophils� �� is released into the �lood and is quickly �ound to and a�sor�ed �y parenchymatous cells of liver and spleen. Under normal conditions� �lood plasma �� concentra-�� concentraconcentration is �.4��.� mg/l. There are some data on significant elevation of �� content in �iological fluids �up to ��� mg/l� upon some pathologies� including cancer� and especially upon inflammatory states� therefore �� content could �e used as a �iochemical marker of inflammation [7] .
An important feature of �� is its capa�ility to �ind with nucleic acids� especially with dou�le-stranded DNA. �� is internali�ed with participation of �� recep-. �� is internali�ed with participation of �� recepis internali�ed with participation of �� receptor along with iron ions �ound with its molecule. Also� Presently there are scarce or no data on the role of �� in the pathogenesis of BC� relation �etween �� content and clinical� morphological and molecular�iologic characteristics of BC at different stages of the disease� as well as �� validity as prognostic criterion for clinical course of BC. Therefore� the aim of the study was to analy�e the patterns of �� expression in tumor cells of BC patients taking into account their �iological properties and clinical features of the disease.
MATERIALS AND METHODS
The clinical specimens of ��� BC patients was ana-��� BC patients was anawas analy�ed [�4]. The assessment of prognostic value of �� for the disease outcome was �ased on a retrospective analysis of the data of ��5 BC patients stages I�II treated in Kyiv Municipal Clinical Oncologic Center in ���5����7. A prospective study of �5� BC patients treated in the same clinics in ��������4 was aimed at an assessment of the relation �etween �� expression in tumors of difexpression in tumors of difin tumors of diftumors of difs of different molecular phenotype and clinical characteristics of BC affecting the course of the disease. All patients provide an informed written consent on the use of individual clinical data for scientific purposes.
All patients received surgical treatment �quadrant-or lumpectomy with regional lymph node dissection� radical mastectomy �y Madden�. The patients with BC of stages І�ІІ were not treated with neoadjuvant therapy. Adjuvant polychemotherapy was performed: CM� �cyclophosphamide� methotrexate� fluorouracyl�� CA� �cyclophosphamide� doxoru�icine� fluorouracyl�� 4�� courses; radiotherapy on postoperative cicatrix and the �one of regional metastases at a total dose of 4��44 �y. The patients with positive expression of hor-4��44 �y. The patients with positive expression of hor�y. The patients with positive expression of hor-. The patients with positive expression of horThe patients with positive expression of horexpression of horof hormone receptors in removed tumor tissue were treated with prolonged hormonal therapy �y standard scheme �tamoxiphene� aromatase inhi�itors� depending on the individual clinical data.
�eneral clinico-pathological characteristics of BC patients are presented in Ta�le �. As one may see� the paTa�le �. As one may see� the paAs one may see� the patients from �oth groups were of similar age� the majority of them �eing at menopause. By histological structure� the most common BC type was invasive ductal cancer of moderate differentiation grade. By the data of molecular-�iologic study� luminal А su�type was diagnosed in the majority of BC patients from �oth groups. All patients were examined with the use of common clinical and la�oratory methods in accordance with the standards for diagnostics and therapy of cancer patients approved �y the orders of Ministry of Health No.�4� of �7.�7.�99� and No.554 of �7.�9.���7. The stage of cancer was estimated according to International TNM classification ������.
�or morphologic research� surgically removed tumor specimens was fixed in ��% neutral formaline solution and further treated �y standard histological method. The preparations were prepared from paraffine �locks� stained with hematoxylin and eosin� and examined using light microscopy.
Immunohistochemical determination of �� expression in the tumors was performed with the use of standard streptavidine-�iotine-peroxydase method on histological slides prepared from paraffine �locks after their fixation in ��% solution of neutral formaline. The 4�5 mm histologic sections were placed on �uper �rost Plus slides ��ermany�. �urther procedures were performed �y routine technique. Anti-�� MoA�s �A�cam� U�A� were used as primary anti�odies. Visuali�ation was done using EnVision system �Dako��AB� system� Denmark�. After detection of peroxydase activity� the slides were stained with Mayer's hematoxylin. Assessment of �� expression was performed �y semiquantitative method. In each histological preparation� �� expression was analy�ed per ���� tumor cells� the num�er of immunopositive and immunonegative cells was expressed in percents acExperimental Oncology ��� �������� ���� ��eptem�er� ��� �������� ���� ��eptem�er� ��eptem�er� ��� counting for the degree of the marker expression �high� moderate� strong�. If the num�er of immunopositive cells was higher than ��%� �� expression was considered as a strong positive one. �or immunohistochemical study of other markers we have used anti�odies against estrogen receptors �ER� �clone �D5�� progesterone receptors �PR� �clone PgR����� epidermal growth factor receptor HER�/neu �clone c-er�B-��� proliferation marker Кі-�7 �clone MIB-�� from DakoСytomation� Denmark. Assessment of expression of mentioned proteins in �reast tumors was performed �y counting immunopositive cells using H-�core method [�5]. Expression from � to ��� scores was considered low� ������� -moderate� and > ��� -high. In the study light microscope Primo �tar �Zeiss� �ermany�� magnification ×����4��� was used.
�tatistical analysis of the data was done with the use of �TATI�TICA �.� program. The relation �etween the indexes was assessed using Pearson's coefficient� its significance analy�ed with the use of χ² test.
RESULTS AND DISCUSSION
Immunohistochemical detection of �� in BC samples revealed a positive ��-specific reaction in cytoplasm of tumor cell in �oth groups of the patients. The num�er of ��-positive ����� tumors in retrospective and pro-��-positive ����� tumors in retrospective and pro-��-positive ����� tumors in retrospective and prospective groups did not differ and at average was equal to 5�.� and 5�.�%� respectively.
In BC patients from group �� �� expression indexes were analy�ed in relation to a num�er of clinical characteristics each of which affecting the clinical course of the disease� in particular� age and menstrual function of the patients� the stage of the disease� histological type of the tumor� its differentiation grade and degree of malignancy� metastasis in regional lymph nodes� receptor status of tumor cells.
The results of correlation analysis evidenced on an a�sence of the difference in the num�ers of ��� tumors dependent on the age of patients with preserved reproductive function ��4 �4�.�%�� and patients at meno-��4 �4�.�%�� and patients at menoand patients at menopatients at menoat menopause �4� �45.4%��. No correlation was found �etween �� expression in tumor� BC stage and histological type of BC. There was o�served a tendency �etween an in-. There was o�served a tendency �etween an inThere was o�served a tendency �etween an increased num�er of ��� tumors in the patients with high differentiated BC ��9 �47.5%�� compared to these with moderately differentiated tumors ��7 �4�.5%�� and low differentiated BC ��7 �4�.4%��.
The num�er of ��� tumors ���%� tended to increase if regional lymph node metastasis N� was present.
As far as receptor status of BC is considered as the most important prognostic marker and an o�jective criterion for hormonal therapy [��]� we have studied a relation �etween an expression of ER in BC cells and �� expression in tumor cells of these patients. Interestingly� in ER-positive �ER�� tumors an expression level of �� was found to �e significantly� nearly twice higher ��5%� than in ER-negative �ER−� tumors ���%� ��ig. ��.
According to the data of literature� regulation of �� synthesis depends on histological type of the cells producing this protein� while amount of �� synthesi�ed in mammary gland is controlled �y prolactin� and its synthesis in reproductive tissue is regulated �y estrogens [�7]. Also� it has �een reported that �� is a ligand for specific receptors on cell surface� which are selective for each histological type [��] . This o�servation could possi�ly explain a high expression level of �� in RE� BC. . In particular� it has �een shown that molecular su�type may serve as an independent prognostic criterion and a prediction factor of an effectiveness of the therapy [��] .
In view of the foregoing� we attempted the prospective study of the relation �etween �� expression in tumors and clinical features of BC including molecular phenotype of the tumors. �� expression was a�out the same in the tumors of patients aged 4��5� and ����9� i.e.� at premenopausal and postmenopausal periods ��ig. ��. Nevertheless� the percentage of ��� tumors decreased in the group of BC patients aged 5����� i.e. at menopause. The stage І and ІІ groups differed neither �y H-score of �� positivity� nor �y the percentage of ��� tumors �Ta�le ��. In �oth groups �stage I and II� the tumors with low �� expression were prevalent ��5.� and 5�.7%� respectively� �see Ta�le ��. Comparison of �� expression in the tumors of difof �� expression in the tumors of difof �� expression in the tumors of dif-�� expression in the tumors of difin the tumors of difthe tumors of difthe tumors of diftumors of difs of difof difof dif-difdifferent histological type revealed significantly higher num�er of ��� cells in invasive ductal carcinoma vs invasive lo�ular carcinoma �see Ta�le ��. In invainvasive lo�ular carcinoma �see Ta�le ��. In invalo�ular carcinoma �see Ta�le ��. In invalo�ular carcinoma �see Ta�le ��. In invacarcinoma �see Ta�le ��. In invacarcinoma �see Ta�le ��. In inva�see Ta�le ��. In invasee Ta�le ��. In invaTa�le ��. In inva-��. In inva-�. In invaIn invasive ductal carcinoma� the percent of the tumors with moderate and high �� expression was significantly higher than the percent of tumors with low �� expression �55.�� vs 44.�7%�. In invasive lo�ular carcinoma� the tumors with low �� expression were prevalent �7�.9� vs ��.�7%�. Also� it was shown that in the tu-.�7%�. Also� it was shown that in the tu-�7%�. Also� it was shown that in the tuAlso� it was shown that in the tu-� it was shown that in the tuit was shown that in the tuwas shown that in the tuwas shown that in the tushown that in the tushown that in the tuthat in the tuthat in the tuin the tuin the tuthe tuthe tutu-tumors of low differentiation grade� �� expression was significantly higher than in the tumors of high or moderate differentiation grade �Ta�le ��. The majority of the patients grouped �y receptor status of the tumor were at postmenopausal period and with prevalently �asal BC phenotype. A large majority of the patients with luminal or �asal tumor su�type were at stage ІІ� luminal B su�type �eing much more frequent. The percentage of luminal А and luminal В molecular su�types in invasive ductal carcinoma was respectively �.� and �.4 times higher than in invasive lo�ular carci-.� and �.4 times higher than in invasive lo�ular carci-� and �.4 times higher than in invasive lo�ular carciand �.4 times higher than in invasive lo�ular carci-�.4 times higher than in invasive lo�ular carci-.4 times higher than in invasive lo�ular carci-4 times higher than in invasive lo�ular carcitimes higher than in invasive lo�ular carcilo�ular carcilo�ular carcicarci-carcinoma. Also� luminal А and luminal В su�types occurred more frequently in moderately differentiated tumors compared to those with high or low differentiation grade� while the percentage of �asal su�type did not differ sig�asal su�type did not differ sigsu�type did not differ signot differ signot differ sigdiffer sigdiffer sigsig-significantly �etween the tumors of different differentiation grade �see Ta�le 4�.
An analysis of �� expression did not reveal significant differences in num�er of ��� cells measured �y H-�core �etween BC of different molecular phenotypes �Ta�le 5�.
We also analy�ed expression of �� in BC with different molecular phenotype taking into acount the most imphenotype taking into acount the most imphenotype taking into acount the most imtaking into acount the most imtaking into acount the most immost immost imim-important prognostic clinical indexes �menstrual function� disease stage� histological type and differentiation grade of a tumor�. It has �een shown that expression of �� in the luminal А tumors was equally frequent in the patients Experimental Oncology ��� �������� ���� ��eptem�er� ��� �������� ���� ��eptem�er� ��eptem�er� ��5
at premenopausal and postmenopausal periods� and was at average higher than in the patients at menopause. Expression of �� in the luminal В tumors did not depend on menstrual function and was significantly higher than in the luminal А tumors. In the tumors with �asal phenothe luminal А tumors. In the tumors with �asal phenothe luminal А tumors. In the tumors with �asal phenoluminal А tumors. In the tumors with �asal phenotumors. In the tumors with �asal pheno-. In the tumors with �asal phenoIn the tumors with �asal phenothe tumors with �asal phenothe tumors with �asal phenotumors with �asal phenotumors with �asal phenowith �asal phenowith �asal pheno�asal phenophenotype� no expression of �� was registered in the patients at premenopausal period while in the patients at menopremenopausal period while in the patients at menopremenopausal period while in the patients at menoperiod while in the patients at menoperiod while in the patients at menowhile in the patients at menowhile in the patients at menoin the patients at menoin the patients at menothe patients at menothe patients at menopatients at menopatients at menoat menoat menomeno-menopause or postmenopausal period high expression levels of �� were o�served which were somewhat lower than that in luminal В tumors �Ta�le ��. Comparison of �� expression in the tumors of different molecular phenotype �etween the groups with different disease stage did not reveal the differences �etween the stages I and II� �ut it has �een noted that at �oth stages expression of �� in tumors with luminal В and �asal su�-of �� in tumors with luminal В and �asal su�-�� in tumors with luminal В and �asal su�-in tumors with luminal В and �asal su�-tumors with luminal В and �asal su�-s with luminal В and �asal su�-with luminal В and �asal su�-with luminal В and �asal su�-luminal В and �asal su�-and �asal su�-�asal su�-su�-types was higher compared to su�type A tumors.
In cases of invasive ductal BC� expression of �� was significantly higher in luminal В tumors than luminal А� and this index was equal in �asal and luminal A su�types. In the case of invasive lo�ular carcinoma� expression of �� was significantly lower in �asal su�type compared to luminal В su�type� �ut was significantly higher than in luminal А su�type �see Ta�le ��.
An analysis of �� expression in tumors of different differentiation grade has shown that in the groups with moderate and low differentiation grades the highest expression of �� was present in luminal В su�type comof �� was present in luminal В su�type com-�� was present in luminal В su�type comwas present in luminal В su�type compresent in luminal В su�type compresent in luminal В su�type comin luminal В su�type comin luminal В su�type comluminal В su�type comsu�type comcomcompared to su�type А. In luminal su�type А tumors of high differentiation grade the indexes of �� expression were slightly lower than these in tumors of low and moderated differentiation grades and equal to these in �asal tumors �see Ta�le ��.
The correlation analysis did not demonstrate correlation of �� expression with the stage of the disease �I or II� in all molecular su�types. In invasive ductal carci-I or II� in all molecular su�types. In invasive ductal carcior II� in all molecular su�types. In invasive ductal carcior II� in all molecular su�types. In invasive ductal carci-II� in all molecular su�types. In invasive ductal carci-II� in all molecular su�types. In invasive ductal carci-� in all molecular su�types. In invasive ductal carciin all molecular su�types. In invasive ductal carciall molecular su�types. In invasive ductal carciall molecular su�types. In invasive ductal carcimolecular su�types. In invasive ductal carcimolecular su�types. In invasive ductal carcisu�types. In invasive ductal carcisu�types. In invasive ductal carcinoma �� expression correlated with occurrence of lumiexpression correlated with occurrence of lumiexpression correlated with occurrence of luminal A su�type while in invasive lo�ular carcinoma expreswhile in invasive lo�ular carcinoma expreswhile in invasive lo�ular carcinoma expreslo�ular carcinoma expreslo�ular carcinoma exprescarcinoma exprescarcinoma expres-expres-expression of �� showed a positive correlation with occurrence of luminal В su�type. In the tumors of �oth histological types with �asal molecular phenotype no correlation was found �Ta�le 7�. �� expression was in a strong positive correlation with occurrence of low and moderate differentiation grade of luminal B or �asal tumors.
Therefore� the present research has shown that expression of �� in BC correlated with some important physiologic and clinical indexes of the disease. The patterns of correlation strongly depended on molecular phenotype of this pathology� i.e. luminal A� luminal B or �asal. According to the data of epidemiologic studies� the development of each particular molecular BC phenotype could �e affected �y many factors including physiologic� constitutive and genetic ones [�9] . �or example� high waist-to-hip ratio is a risk factor for postmenopausal luminal and �asal carcinoma. It is known that �asal BC su�-type develops more frequently in young Afro-American women compared to white women. There are some studies repor ting that �asal carcinoma development could �e prevented �y weight control and prolonged �reast feeding [��] . By the data of genetic studies� the majority of BRCA1-associated tumors are of �asal su�type� while in the cases with mutated BRCA2 the tumors are mostly of luminal А and В su�types [��] . In general� the data of literature evidence that molecular pathogenesis of BC strongly depends on physiologic and genetic factors [�4]� and molecular BC su�types represent different forms of the disease with different etiology and pathogenesis.
Along with this� some recent pu�lications demonstrate that �iologic heterogeneity of BC could as well �e affected �y the heterogeneity of expression of molecular markers that determine BC phenotype� and important signal pathways involved in the development and progression of the tumors [��� ��]. In particular� �y the data of cluster microanalysis� it has �een considered reasona�le to classify Her�-positive su�type into three separate su�types �ecause one of them is characteri�ed �y more unfavora�le prognosis than two others [�4]. Also� one should take into account the existence of two forms of ER -ER� and ERβ� as far as the latter is differently expressed in molecular su�types of BC [�5]. Hyper expression of ERβ is the highest in �asal BC su�-type and serves as a negative prognostic factor; �y multifactor analysis� it is considered to �e an independent risk factor of BC. It is supposed that screening of BC patients �y expression of ERβ and ER� may help to assess proliferative activity of the tumors and to make prognostic indexes more accurate. Taking into account �iological properties of �� and wide range of its functional activities� we propose to consider �� as an integral �iological index reflecting different changes associated with tumor cell heterogeneity in a neoplasm� and with individual response of an organism on particular tumor phenotype. �uch idea is supported �y the recent data on capa�ility of DNA� different nucleotides and oligosaccharides to affect the formation of �� oligomers that differ �y antioxidant and antitumor activities and �y their interaction with the components of immune system [��] .
The results of the present study on the correlation �etween the expression of �� in �reast tumors with life expectancy of BC patients are of special importance. It seems reasona�le to find the ways of �� correction in BC patients taking into account the individual patterns of clinical course of the disease and tumor heterogeneity. 
